We commenced stage 2 of the post-listing review on surgical guides and biomodels listed on the Prescribed List (PL). Stage 2 will focus on an economic assessment of surgical guides and biomodels and provide options for benefit setting on the PL.
Stage 2 will follow the process in the post-listing review framework.
The department has engaged an external consultant to:
- review the evidence for cost-effectiveness of surgical guides and biomodels
- conduct an appropriate economic analysis of the devices in scope.
Sponsors and relevant stakeholders have been notified and invited to submit relevant information.
Updates on the progress of the review will be provided via the department’s website.
For background on stage 1 of the review refer to the surgical guides and biomodels post-listing review webpage.